Bota Bio Celebrates Five Years: Bringing Synthetic Biology into Everyday Life

From natural flavorings and nutritional supplements to bio-based raw materials and high-efficacy skincare active ingredients, the boundaries of synthetic biology’s everyday applications are continuously expanding. The challenge of translating laboratory innovations into broader commercial success—bringing them into supermarkets, restaurants, and even households—has become an inexhaustible driving force for synthetic biology innovators to pursue technological maturity, scale-up, cost reduction, and accelerated commercialization.

On September 26, the “Frontier Bioscience Exploration Forum: Evolution and Breakthroughs—Bringing Biotechnology into Daily Life,” hosted by Bota Bio, concluded successfully in Hangzhou. The forum brought together experts and scholars, partners, investors, and industry representatives from government, enterprise, academia, and research institutions. Participants shared Bota Bio’s development journey and notable achievements over the past five years, outlined opportunities for the next five years, and discussed the latest advances in synthetic biology and their practical applications across multiple industries.

For synthetic biology companies, technology platforms are as important as products. From its inception to the commercialization stage, Bota Bio has leveraged its team’s strengths to first establish a cutting-edge technology platform, thereby deeply integrating into the industry, selecting niche sectors for in-depth development based on market demand, and achieving industrial implementation.

Over the past five years, Bota Bio has built Bota Freeway, a high-throughput automated platform for strain and process development.^®Biofoundry enables end-to-end coverage of synthetic biology, from laboratory R&D to industrial-scale production. The platform’s advantages lie in its intelligent design capabilities and systematic, high-throughput engineering capabilities, particularly in the development of non-model industrial strains, which have become a key distinguishing feature of Bota Bio’s R&D platform compared to other technology platforms.

Addressing the critical bottleneck in biomanufacturing—industrial scale-up and commercialization—Bota Bio leverages extensive data and accumulated scientific expertise to achieve industrial scale-up through a more comprehensive, multidisciplinary approach. This facilitates the large-scale production of research outcomes and accelerates the translation of technological innovations into industrial value.

In July 2024, Bota Bio and NHU, a leading enterprise in fine chemicals, announced that their first collaborative project had successfully achieved commercialization, building on their strategic partnership. This collaboration demonstrates Bota Bio’s capability to scale its biotechnology from the laboratory to large-scale industrial production.

The successful collaboration with NHU has strongly validated Bota Bio’s development strategy: leveraging its core technological capabilities as a foundation, partnering with leading enterprises across various industries, and establishing a global synthetic biology industry chain. This approach accelerates Bota Bio’s rapid entry into the industrial sector, enabling technology to empower industry. Bota Bio remains firmly committed to this strategy in its deep cultivation of specialized segments.

In the food sector, Bota Bio adheres to the product selection philosophy of “healthier and safer,” committing to driving continuous technological iteration by building a diversified product matrix and leveraging advantages such as intelligent manufacturing. The company has chosen bio-preservation as its entry point into this niche market, establishing effective market barriers to ensure its leading position in this segment. Horizontally, the company has established a comprehensive portfolio of bio-preservative and anti-spoilage products. Vertically, through the development of compound formulation technologies and clean-label products, Bota Bio closely aligns with customer needs, providing holistic solutions tailored to specific application scenarios.

Bota Bio has entered into a technical development collaboration with Puratos, a global leader in ingredients for bread, pastry, and chocolate. By leveraging Puratos’ extensive expertise in food and baking science alongside Bota Bio’s advanced enzyme mining and engineering technologies, the partnership aims to expand Puratos’ portfolio of natural enzymes to meet the growing market demand for natural ingredients.

In the skincare sector, Bota Bio has established a wholly-owned subsidiary, Qingran Xinhu (Yucca Elements), and launched multiple bio-identical protein-based personal care ingredients. This product series not only features technologically innovative ingredients that enhance the skin’s natural healing capacity but also includes high-quality components with anti-aging efficacy that activate gene expression in the deeper layers of the skin. Currently, these ingredients have been incorporated into products by leading domestic skincare companies and have received widespread acclaim.

2024 marks the fifth year since the establishment of Bota Bio, representing another milestone as the company embarks on a new journey. Moving forward, Bota Bio will remain true to its original mission, continuing to drive the transition from digitalization to intelligence, enhancing R&D efficiency, and delivering superior biomanufacturing solutions tailored to industry needs and pain points. We look forward to collaborating with experts, scholars, industry partners, and investors to jointly promote continuous evolution and breakthroughs in the field of synthetic biology.